SCHEMBL6678043

SCHEMBL6678043

COc1cc2c(C(F)(F)F)c([N+](=O)[O-])c(=O)n(CN3C(=O)c4ccccc4C3=O)c2cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MASP2 O00187 1/20 0.37
F2 P00734 1/20 0.37
PGR P06401 1/20 0.36
RORA P35398 1/20 0.36
RORC P51449 1/20 0.36
RORB Q92753 1/20 0.36
TP53 P04637 1/20 0.36
AGTR1 P30556 2/20 0.36
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6678046 0.83 RAB9A (0.37) LMNAALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL6679443 0.78 TP53 (0.51) LMNAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL28396699 0.66 TP53 (0.50) ALDH1A1SMN1; SMN2KDM4ETP53POLB
SCHEMBL6675262 0.64 KDM4E (0.56) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL11445232 0.64 KMT2A (0.53) LMNAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL6679445 0.63 KMT2A (0.40) LMNAALDH1A1HPGDSMN1; SMN2TP53
SCHEMBL11445559 0.63 RXFP1 (0.40) LMNAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL11445221 0.62 RXFP1 (0.50) LMNAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL6677065 0.62 S100B (0.42) ALDH1A1HPGDSMN1; SMN2KDM4EHSD17B10
SCHEMBL11445049 0.62 MEN1 (0.40) LMNAALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1181341-B1 LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF URAY GEORG (AT) 2004-10-27 EP disclosed
US-6635759-B2 Used as luminescent marker for peptides, proteins, RNA and DNA, as complexing agent Uray, Georg (AT) 2003-10-21 US disclosed
US-20020058793-A1 Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use AGILENT TECHNOLOGIES, INC. 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058793-A1 Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use CYP4F2, CYP4F12, CRY1 LMNA 943/4885ALDH1A1 1430/4885HPGD 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.